Compugen Ltd (CGEN) SEC Filing 6-K Foreign Issuer report for the period ending Tuesday, July 2, 2019

Compugen Ltd

CIK: 1119774 Ticker: CGEN

View differences made from one to another to evaluate Compugen Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Compugen Ltd.


Assess how Compugen Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Compugen Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Compugen Ltd provided additional information to their SEC Filing as exhibits

Ticker: CGEN
CIK: 1119774
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001178913-19-001803
Submitted to the SEC: Tue Jul 02 2019 7:00:14 AM EST
Accepted by the SEC: Tue Jul 02 2019
Period: Tuesday, July 2, 2019
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: